4//SEC Filing
WELCH DANIEL G 4
Accession 0001203311-23-000087
CIK 0001060736other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:22 PM ET
Size
12.9 KB
Accession
0001203311-23-000087
Insider Transaction Report
Form 4
Seagen Inc.SGEN
WELCH DANIEL G
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-28$135.63/sh+1,812$245,762→ 10,109 total - Sale
Common Stock
2023-08-28$209.01/sh−1,812$378,726→ 6,794 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-08-28−1,812→ 0 totalExercise: $135.63From: 2023-05-13Exp: 2032-05-13→ Common Stock (1,812 underlying) - Sale
Common Stock
2023-08-28$209.08/sh−1,610$336,619→ 10,725 total(indirect: By Trust) - Sale
Common Stock
2023-08-28$209.16/sh−1,503$314,367→ 8,606 total
Footnotes (6)
- [F1]Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- [F2]Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F3]Reflects sales of common stock executed in multiple transactions at prices ranging from $209.06 to $209.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]Reflects sales of common stock executed in multiple transactions at prices ranging from $208.92 to $209.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F5]Reflects sales of common stock executed in multiple transactions at prices ranging from $208.92 to $209.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F6]Options vested in full on 5/13/23.
Documents
Issuer
Seagen Inc.
CIK 0001060736
Entity typeother
Related Parties
1- filerCIK 0001206199
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:22 PM ET
- Size
- 12.9 KB